The FDA has finalized its recommendations for getting AI-equipped medical devices approved. 

RadNet Inc. presented new research at RSNA 2024, showing that women who paid $40 for an AI add-on experienced a 21% higher breast cancer detection rate. 

Founded in 2017, the Denver-based company offers an artificial intelligence solution that analyzes coronary CT angiography images for signs of heart disease. 

Eve Lee, MBA, succeeds Keith M. Hume, who left SIR's top post in May to pursue other opportunities after three years on the job.  

A large venture capital firm focused on supporting early-stage healthtech companies has a tip for AI startups targeting the healthcare sector.

After announcing it would place time limits on reimbursement for the time a patient is under anesthesia, Anthem Blue Cross Blue Shield has now denied it ever intended to make the change. 

The NYPD is offering a $10,000 award for “information leading to an arrest and conviction.” No arrests have been made and the killer has yet to be identified. 

With the number of FDA approved AI-enabled applications nearing 1,000, it’s clear the healthcare industry is ready to embrace the evolving technology.

This was a moment years in the making for interventional cardiology. A total of 164 training programs participated, and 94% of applicants secured a position. 

The news comes at the end of a busy year for Cleerly. The company says it will use the funds to grow commercially and generate more evidence in support of its FDA-approved technology.